scrfi  (New England Biolabs)


Bioz Verified Symbol New England Biolabs is a verified supplier
Bioz Manufacturer Symbol New England Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    New England Biolabs scrfi
    a A normal DNA, B and H <t>PCR</t> product uncut with Pst1, C and K heterozygous mutant-type cut with Scrf1: 194 bp and 174 bp fragmented and E negative control (water) M DNA marker. b Heterozygous mutant-type: 194 bp and 174 bp fragment by screening of PCR products using restriction enzymes <t>ScrfI</t> and PstI; A1 , heterozygous patient; B1 , C , and D homozygous normal
    Scrfi, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/scrfi/product/New England Biolabs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    scrfi - by Bioz Stars, 2022-05
    93/100 stars

    Images

    1) Product Images from "An association study between CHEK2 gene mutations and susceptibility to breast cancer"

    Article Title: An association study between CHEK2 gene mutations and susceptibility to breast cancer

    Journal: Comparative Clinical Pathology

    doi: 10.1007/s00580-017-2455-x

    a A normal DNA, B and H PCR product uncut with Pst1, C and K heterozygous mutant-type cut with Scrf1: 194 bp and 174 bp fragmented and E negative control (water) M DNA marker. b Heterozygous mutant-type: 194 bp and 174 bp fragment by screening of PCR products using restriction enzymes ScrfI and PstI; A1 , heterozygous patient; B1 , C , and D homozygous normal
    Figure Legend Snippet: a A normal DNA, B and H PCR product uncut with Pst1, C and K heterozygous mutant-type cut with Scrf1: 194 bp and 174 bp fragmented and E negative control (water) M DNA marker. b Heterozygous mutant-type: 194 bp and 174 bp fragment by screening of PCR products using restriction enzymes ScrfI and PstI; A1 , heterozygous patient; B1 , C , and D homozygous normal

    Techniques Used: Polymerase Chain Reaction, Mutagenesis, Negative Control, Marker

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    New England Biolabs scrfi
    a A normal DNA, B and H <t>PCR</t> product uncut with Pst1, C and K heterozygous mutant-type cut with Scrf1: 194 bp and 174 bp fragmented and E negative control (water) M DNA marker. b Heterozygous mutant-type: 194 bp and 174 bp fragment by screening of PCR products using restriction enzymes <t>ScrfI</t> and PstI; A1 , heterozygous patient; B1 , C , and D homozygous normal
    Scrfi, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/scrfi/product/New England Biolabs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    scrfi - by Bioz Stars, 2022-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    a A normal DNA, B and H PCR product uncut with Pst1, C and K heterozygous mutant-type cut with Scrf1: 194 bp and 174 bp fragmented and E negative control (water) M DNA marker. b Heterozygous mutant-type: 194 bp and 174 bp fragment by screening of PCR products using restriction enzymes ScrfI and PstI; A1 , heterozygous patient; B1 , C , and D homozygous normal

    Journal: Comparative Clinical Pathology

    Article Title: An association study between CHEK2 gene mutations and susceptibility to breast cancer

    doi: 10.1007/s00580-017-2455-x

    Figure Lengend Snippet: a A normal DNA, B and H PCR product uncut with Pst1, C and K heterozygous mutant-type cut with Scrf1: 194 bp and 174 bp fragmented and E negative control (water) M DNA marker. b Heterozygous mutant-type: 194 bp and 174 bp fragment by screening of PCR products using restriction enzymes ScrfI and PstI; A1 , heterozygous patient; B1 , C , and D homozygous normal

    Article Snippet: PCR products were separately incubated for 16 h with either ScrFI or PstI (New England Bio labs, Beverly, MA).

    Techniques: Polymerase Chain Reaction, Mutagenesis, Negative Control, Marker